LPCN MEXC RealStocks
Own real LPCN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 20:40:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Lipocine Inc. (LPCN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.61, with a market capitalization of $17.61M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.36 to $12.37. This page covers its latest market performance, valuation, price trends and company information.
$17.61M | |
$1.58 | |
$1.62 | |
$1.52 | |
$1.59 | |
81.28K | |
1.86M | |
-- | |
$12.37 | |
$1.36 | |
-- | |
-- |
Lipocine Inc. (LPCN) is currently trading at $1.61 as of 2026-11-12 20:39:00, up 0.31% ($0.00) from the previous close of $1.59
During today's regular trading session, LPCN has traded between $1.52 and $1.62, with a trading volume of 81.28K shares. The current price is near the upper end of today's range.
Over the past seven days, Lipocine Inc. (LPCN) moved from $1.46 to $1.61, representing a gain of 10.27% ($0.15).
The stock traded between $1.40 and $1.74 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 264.89 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 2.3%
LPCN is currently trading at $1.61, placing it 2.3% of the way from its 52-week low of $1.36 to its 52-week high of $12.37. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Lipocine Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Lipocine Inc. (LPCN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LPCN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LPCN shares and USD.
LPCN Shares to USD
1.00 LPCN shares = 1.61 USD
Calculations are estimates based on the latest available price and are for reference only.